Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

1 Known hypersensitivity or idiosyncratic reaction to Chlorine or any of related substance or ingredient of the formulation. <br/ >2 Patient having past history of respiratory disorder like COPD, Asthma etc. <br/ >3 Patient is on medication before tested nCOVID 19 positive for respiratory disease or disorder (other than viral infection). <br/ >4 Patients who are diagnosed and/or on treatment for venous thromboembolism, ischemic heart disease, myocardial infarction, congestive cardiac failure, unexplained vaginal bleeding with suspicion of serious underlying condition, history of breast or cervical cancer, malignant tumor <br/ >5 Patient of Hypertension and/or Diabetes who was not on stable treatment in past 3 month. <br/ >6 Patient was on immunomodulatory drug <br/ >7 Have participated in other clinical study related to nCOVID 19 <br/ >8 Patients with other severe acute or chronic conditions that may increase the risk of participation in the study and study treatment, or may interfere with interpretation of study results, and judged by the investigator as not suitable for participation in this clinical trial. <br/ >9 Known history of Chronic Kidney disease <br/ >10 Known history of Chronic Liver disease <br/ >11 Nursing mother or pregnant women

1 Known hypersensitivity or idiosyncratic reaction to Chlorine or any of related substance or ingredient of the formulation. <br/ >2 Patient having past history of respiratory disorder like COPD, Asthma etc. <br/ >3 Patient is on medication before tested nCOVID 19 positive for respiratory disease or disorder (other than viral infection). <br/ >4 Patients who are diagnosed and/or on treatment for venous thromboembolism, ischemic heart disease, myocardial infarction, congestive cardiac failure, unexplained vaginal bleeding with suspicion of serious underlying condition, history of breast or cervical cancer, malignant tumor <br/ >5 Patient of Hypertension and/or Diabetes who was not on stable treatment in past 3 month. <br/ >6 Patient was on immunomodulatory drug <br/ >7 Have participated in other clinical study related to nCOVID 19 <br/ >8 Patients with other severe acute or chronic conditions that may increase the risk of participation in the study and study treatment, or may interfere with interpretation of study results, and judged by the investigator as not suitable for participation in this clinical trial. <br/ >9 Known history of Chronic Kidney disease <br/ >10 Known history of Chronic Liver disease <br/ >11 Nursing mother or pregnant women

Nov. 13, 2021, 5:33 p.m. oms

N/A

N/A

Sept. 8, 2021, 1:30 a.m. oms

1 Known hypersensitivity or idiosyncratic reaction to Chlorine or any of related substance or ingredient of the formulation. <br/ >2 Patient having past history of respiratory disorder like COPD, Asthma etc. <br/ >3 Patient is on medication before tested nCOVID 19 positive for respiratory disease or disorder (other than viral infection). <br/ >4 Patients who are diagnosed and/or on treatment for venous thromboembolism, ischemic heart disease, myocardial infarction, congestive cardiac failure, unexplained vaginal bleeding with suspicion of serious underlying condition, history of breast or cervical cancer, malignant tumor <br/ >5 Patient of Hypertension and/or Diabetes who was not on stable treatment in past 3 month. <br/ >6 Patient was on immunomodulatory drug <br/ >7 Have participated in other clinical study related to nCOVID 19 <br/ >8 Patients with other severe acute or chronic conditions that may increase the risk of participation in the study and study treatment, or may interfere with interpretation of study results, and judged by the investigator as not suitable for participation in this clinical trial. <br/ >9 Known history of Chronic Kidney disease <br/ >10 Known history of Chronic Liver disease <br/ >11 Nursing mother or pregnant women

1 Known hypersensitivity or idiosyncratic reaction to Chlorine or any of related substance or ingredient of the formulation. <br/ >2 Patient having past history of respiratory disorder like COPD, Asthma etc. <br/ >3 Patient is on medication before tested nCOVID 19 positive for respiratory disease or disorder (other than viral infection). <br/ >4 Patients who are diagnosed and/or on treatment for venous thromboembolism, ischemic heart disease, myocardial infarction, congestive cardiac failure, unexplained vaginal bleeding with suspicion of serious underlying condition, history of breast or cervical cancer, malignant tumor <br/ >5 Patient of Hypertension and/or Diabetes who was not on stable treatment in past 3 month. <br/ >6 Patient was on immunomodulatory drug <br/ >7 Have participated in other clinical study related to nCOVID 19 <br/ >8 Patients with other severe acute or chronic conditions that may increase the risk of participation in the study and study treatment, or may interfere with interpretation of study results, and judged by the investigator as not suitable for participation in this clinical trial. <br/ >9 Known history of Chronic Kidney disease <br/ >10 Known history of Chronic Liver disease <br/ >11 Nursing mother or pregnant women